Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives $26.85 Average PT from Analysts

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has been given an average rating of “Hold” by the fifteen brokerages that are covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, five have given a hold recommendation, seven have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $26.8462.

A number of analysts have commented on ACHC shares. Guggenheim lifted their target price on shares of Acadia Healthcare from $26.00 to $31.00 and gave the stock a “buy” rating in a report on Monday, May 4th. TD Cowen raised their price target on Acadia Healthcare from $24.00 to $30.00 and gave the stock a “buy” rating in a research report on Tuesday, April 28th. Royal Bank Of Canada lifted their price objective on Acadia Healthcare from $28.00 to $31.00 and gave the stock an “outperform” rating in a research note on Monday, May 4th. KeyCorp reissued an “overweight” rating and issued a $30.00 target price on shares of Acadia Healthcare in a research note on Wednesday, May 27th. Finally, UBS Group raised their target price on Acadia Healthcare from $27.00 to $31.00 and gave the stock a “buy” rating in a report on Friday, April 17th.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in ACHC. Militia Capital Management LLC bought a new position in Acadia Healthcare during the first quarter worth about $2,842,000. Glenmede Trust Co. NA bought a new position in Acadia Healthcare in the first quarter valued at approximately $239,000. Segall Bryant & Hamill LLC acquired a new position in Acadia Healthcare during the first quarter valued at approximately $263,000. Bank of America Corp DE lifted its stake in Acadia Healthcare by 64.7% during the first quarter. Bank of America Corp DE now owns 1,231,172 shares of the company’s stock worth $28,797,000 after purchasing an additional 483,649 shares during the last quarter. Finally, Amundi boosted its holdings in shares of Acadia Healthcare by 2.9% in the 1st quarter. Amundi now owns 525,084 shares of the company’s stock valued at $12,282,000 after purchasing an additional 14,796 shares in the last quarter.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC traded up $0.47 during trading on Tuesday, reaching $31.56. The stock had a trading volume of 842,570 shares, compared to its average volume of 3,376,033. The stock has a market capitalization of $2.90 billion, a PE ratio of -2.58, a P/E/G ratio of 10.64 and a beta of 0.64. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71. Acadia Healthcare has a 52 week low of $11.43 and a 52 week high of $32.82. The business’s 50-day moving average price is $25.78 and its 200 day moving average price is $21.40.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.09. The firm had revenue of $828.80 million during the quarter, compared to the consensus estimate of $823.51 million. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The business’s revenue for the quarter was up 7.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. As a group, equities analysts predict that Acadia Healthcare will post 1.5 earnings per share for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.